Johnson & Johnson (NYSE: JNJ) reported its Q3 2021 earnings on October 19th and beat EPS estimates by nearly 10%.…
Read More »Biotech
Nearly two years since the COVID-19 pandemic began and almost one year since the various COVID-19 vaccines started to roll…
Read More »
Unlike the many other mundane weekly news recaps, the team at Wealthy VC has made it its mission to scour…
Read More »